全文获取类型
收费全文 | 9765篇 |
免费 | 755篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 282篇 |
妇产科学 | 221篇 |
基础医学 | 1586篇 |
口腔科学 | 448篇 |
临床医学 | 769篇 |
内科学 | 2328篇 |
皮肤病学 | 276篇 |
神经病学 | 831篇 |
特种医学 | 233篇 |
外科学 | 1129篇 |
综合类 | 89篇 |
一般理论 | 2篇 |
预防医学 | 824篇 |
眼科学 | 164篇 |
药学 | 646篇 |
中国医学 | 73篇 |
肿瘤学 | 601篇 |
出版年
2023年 | 122篇 |
2022年 | 114篇 |
2021年 | 391篇 |
2020年 | 269篇 |
2019年 | 397篇 |
2018年 | 376篇 |
2017年 | 291篇 |
2016年 | 335篇 |
2015年 | 340篇 |
2014年 | 416篇 |
2013年 | 527篇 |
2012年 | 759篇 |
2011年 | 777篇 |
2010年 | 401篇 |
2009年 | 321篇 |
2008年 | 540篇 |
2007年 | 524篇 |
2006年 | 513篇 |
2005年 | 507篇 |
2004年 | 412篇 |
2003年 | 398篇 |
2002年 | 318篇 |
2001年 | 133篇 |
2000年 | 154篇 |
1999年 | 130篇 |
1998年 | 73篇 |
1997年 | 46篇 |
1996年 | 33篇 |
1995年 | 36篇 |
1994年 | 30篇 |
1993年 | 41篇 |
1992年 | 90篇 |
1991年 | 68篇 |
1990年 | 65篇 |
1989年 | 60篇 |
1988年 | 58篇 |
1987年 | 62篇 |
1986年 | 40篇 |
1985年 | 48篇 |
1984年 | 40篇 |
1983年 | 52篇 |
1982年 | 28篇 |
1981年 | 27篇 |
1980年 | 17篇 |
1979年 | 29篇 |
1978年 | 19篇 |
1976年 | 24篇 |
1974年 | 22篇 |
1973年 | 16篇 |
1971年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
1.
Toshiro Hara Rony Chanoch-Myers Nathan D. Mathewson Chad Myskiw Lyla Atta Lillian Bussema Stephen W. Eichhorn Alissa C. Greenwald Gabriela S. Kinker Christopher Rodman L. Nicolas Gonzalez Castro Hiroaki Wakimoto Orit Rozenblatt-Rosen Xiaowei Zhuang Jean Fan Tony Hunter Inder M. Verma Kai W. Wucherpfennig Itay Tirosh 《Cancer cell》2021,39(6):779-792.e11
2.
Andrea Ferrari MD Daniel Orbach MD Michela Casanova MD Max M. van Noesel MD Pablo Berlanga MD Bernadette Brennan MD Nadege Corradini MD Reineke A. Schoot MD Gema L. Ramirez-Villar MD Lisa Lyngsie Hjalgrim MD Rita Alaggio MD Gabriela Guillen Burrieza MD Akmal Safwat MD Alison L. Cameron MD Rick R. van Rijn MD Veronique Minard-Colin MD Ilaria Zanetti BSc Gianni Bisogno MD Julia C. Chisholm MD Johannes H. M. Merks MD 《Cancer》2023,129(16):2542-2552
Background
Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined.Methods
This cohort study reports on pediatric adult-type metastatic NRSTS enrolled in two concurrent prospective European studies, i.e., the randomized BERNIE study and the single-arm MTS 2008 study developed by the European paediatric Soft tissue sarcoma Study Group. Treatment programs were originally designed for patients with metastatic rhabdomyosarcoma, i.e., nine courses of multidrug chemotherapy (with or without bevacizumab in the BERNIE study), followed by 12 cycles of maintenance therapy, whereas radiotherapy and/or surgery (on primary tumor and/or metastases) were delayed until after seven courses of chemotherapy had been administered.Results
The study included 61 patients <21 years old treated from July 2008 to December 2016. The lung was the site of metastases in 75% of the cases. All patients received multi-agent chemotherapy, 44% had local therapy to primary tumor, and 18% had treatment of metastases. Median time to progression/relapse was 6 months. A high rate of tumor progression was observed during the initial part of the chemotherapy program. With a median follow-up of 41.5 months (range, 2–111 months), 3-year event-free survival and overall survival were 15.4% (95% confidence interval [CI], 7.6–25.7) and 34.9% (95% CI, 22.7–47.5), respectively. There were no statistically significant differences in outcome depending on the type of treatment administered.Conclusions
The study confirmed the overall poor outcome for patients with metastatic NRSTS, whose treatment remains a challenge.Plain Language Summary
- Pediatric non-rhabdomyosarcoma soft tissue sarcomas form a heterogeneous group of rare tumors.
- Although recent international studies have defined the standard of care for patients with localized disease, limited data are available on the clinical behavior of patients with distant metastases.
- This study on 61 metastatic cases treated on two prospective European protocols confirms that the chances of survival of such patients are often dismal and a standard treatment is still lacking.
3.
4.
5.
6.
7.
8.
Topical Treatment of Oral Mucositis in Cancer Patients: A Systematic Review of Randomized Clinical Trials 下载免费PDF全文
Geisa Sant AnaAna Gabriela Costa NormandoIsabela de Toledo Paula Elaine Diniz dos ReisEliete Neves Silva Guerra 《Asian Pacific journal of cancer prevention》2020,21(7):1851-1866
Background and Purpose: Evidence-based protocols of topical therapy for oral mucositis (OM) induced by chemoradiotherapy (CRT) are continuously established and updated. Thus, the present systematic review aims to evaluate the scientific literature in terms of effectiveness of topical treatment of OM in cancer patients undergoing CRT. Materials and Methods: This systematic review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist. Randomized clinical trials were identified through electronic database searches on CINAHL, Cochrane Library, LILACS, Livivo, PubMed, SCOPUS, and Web of Science. Grey literature was also assessed on Google Scholar, Open Grey, and ProQuest. The risk of bias in the included studies was assessed by the Cochrane Collaboration Risk of Bias Tool. Results: Twenty-three randomized clinical trials (n=1169 patients) met the inclusion criteria. Twenty-three different topical agents were examined and categorized into five groups: analgesics (30.4%), natural agents (21.7%), other topical agents (21.7%), antimicrobial agents (17.4%), and growth factors (8.8%). Of the included studies, 50% presented a resolution of OM within 14 days. Topical natural agents yielded good results with average resolution time of 3–7 days. The included studies generally demonstrated that patients treated with mouthwashes presented superior benefits compared to the control, depending on OM severity. Conclusion: Topical agents effectively reduced the severity of OM lesions and pain intensity in patients receiving chemoradiotherapy, although the effects varied by agent type. However, the heterogeneity in the results of these topical intervention studies underscores the need for standardized clinical trial methodologies. Clinical Relevance: Topical agents were effective in patients with severe OM lesions receiving chemoradiotherapy and are a good alternative of home care in relation to pain control, reduction of inflammation and consequent improvement in quality of life. 相似文献
9.